Enzymatic Therapy strategy
This article was originally published in The Tan Sheet
Executive Summary
Only about 1% of 1,044 structure/function claims submitted in the past year have been cited in FDA "courtesy" letters, according to Green Bay, Wisc.-based firm, which notes its strategy is to "submit claims we have no serious intention of using...to help us better understand FDA's interpretation of the law." Approach accounts for firm's receipt of roughly 18 "courtesy" letters in past year, as reported in 1"The Tan Sheet" May 27, 2002, p. 7...
Only about 1% of 1,044 structure/function claims submitted in the past year have been cited in FDA "courtesy" letters, according to Green Bay, Wisc.-based firm, which notes its strategy is to "submit claims we have no serious intention of using...to help us better understand FDA's interpretation of the law." Approach accounts for firm's receipt of roughly 18 "courtesy" letters in past year, as reported in 1 (Also see "“Dry Throat” Not A Disease, “Soothe” A Cosmetic Claim, Tom’s Of Maine Says" - Pink Sheet, 27 May, 2002.), p. 7.... |